EUVIMEDEUVIMED entdecken
Open Access

Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats

Asadur Rahman iD, Tatsuya Sawano iD, Kento Kitada iD, Nourin Jahan iD, Yoshihide Fujisawa, Keiko Yamakawa, Md Moshiur Rahman iD, Juanjuan Ye, Md Enayet Kabir iD, Kyuichi Kadota, Takeshi Imamura, Hiroyuki Ohsaki iD und 4 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.044798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Asadur Rahman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine Kagawa University Takamatsu Kagawa Japan. Hauptthemen laut MEDLINE: Aldosterone, Myocardium, Mineralocorticoid Receptor Antagonists, Naphthyridines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical trials have indicated that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, elicits considerable cardiovascular protective benefits; however, its precise mechanism of action remains to be fully elucidated.

Methods

Here, we examined the impact of finerenone on myocardial injury and sodium accumulation in uninephrectomy male Sprague‐Dawley rats subjected to chronic aldosterone infusion (0.75 μg/h) and salt‐loading (1% NaCl) in drinking water for 4 weeks.

Results

Echocardiographic assessments and gene expression analyses revealed adverse cardiac remodeling and ventricular dysfunction with preserved ejection fraction in aldosterone/salt‐loaded uninephrectomy rats. Notably, finerenone (10 mg/kg) treatment completely prevented the development of cardiac dysfunction in these animals. Additionally, sodium content in left ventricular tissues was markedly elevated in aldosterone/salt‐loaded uninephrectomy rats, which was attenuated by finerenone treatment. Furthermore, a significant increase in macrophage recruitment was observed in cardiac tissues with markedly elevated M1 macrophage populations. However, finerenone treatment effectively prevented migration as well as polarization of macrophage in cardiac tissue. In an in vitro assay using RAW264.7 cells, a macrophage cell line, finerenone dramatically reduced the aldosterone/salt‐induced elevation of M1 markers, whereas M2 markers exhibited a tendency to increase, potentially linked to NFAT5 (nuclear factor of activated T‐cells 5)‐ and IL (interleukin)‐10‐mediated pathways.

Conclusions

These findings suggest that finerenone inhibits cardiac dysfunction induced by aldosterone/salt through the suppression of sodium accumulation in left ventricular tissues and attenuate subsequent macrophage‐mediated inflammation, thereby preventing adverse cardiac remodeling and dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AldosteroneMyocardiumMineralocorticoid Receptor AntagonistsNaphthyridinesSodiumSodium Chloride, DietaryVentricular Dysfunction, LeftAnimalsMaleRats, Sprague-DawleyVentricular RemodelingDisease Models, AnimalMacrophagesVentricular Function, LeftRatsNephrectomy

Stichwörter der Autor:innen

aldosteronecardiovascular diseasesfinerenonemineralocorticoid receptor antagonistsalt

Substanzen

AldosteronefinerenoneMineralocorticoid Receptor AntagonistsNaphthyridinesSodiumSodium Chloride, Dietary

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine Kagawa University Takamatsu Kagawa Japan.
  • Division of Pharmacology, Faculty of Medicine Tottori University Yonago Japan.
  • Molecular Oncologic Pathology, Department of Pathology and Host-Defense, Faculty of Medicine Kagawa University Takamatsu Kagawa Japan.
  • Department of Medical Biophysics Kobe University Graduate School of Health Sciences Kobe Japan.
  • Department of Clinical Medical Technology, Faculty of Medical Science Juntendo University Tokyo Japan.
  • Division of Nephrology and Hypertension Osaka City General Hospital Osaka Japan.

ORCID-Profile: Asadur Rahman, Tatsuya Sawano, Kento Kitada, Nourin Jahan, Md Moshiur Rahman, Md Enayet Kabir, Hiroyuki Ohsaki, Daisuke Yamazaki, Yoshio Konishi, Akira Nishiyama

Zitieren

APA

Rahman, A., Sawano, T., Kitada, K., Jahan, N., Fujisawa, Y., Yamakawa, K., Rahman, M. M., Ye, J., Kabir, M. E., Kadota, K., Imamura, T., Ohsaki, H., Yamazaki, D., Morikawa, T., Konishi, Y., & Nishiyama, A. (2026). Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044798

Vancouver

Rahman A, Sawano T, Kitada K, Jahan N, Fujisawa Y, Yamakawa K, et al. Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044798

BibTeX
@article{Rahman2026,
  author = {Rahman, Asadur and Sawano, Tatsuya and Kitada, Kento and Jahan, Nourin and Fujisawa, Yoshihide and Yamakawa, Keiko and Rahman, Md Moshiur and Ye, Juanjuan and Kabir, Md Enayet and Kadota, Kyuichi and Imamura, Takeshi and Ohsaki, Hiroyuki and Yamazaki, Daisuke and Morikawa, Takashi and Konishi, Yoshio and Nishiyama, Akira},
  title = {Cardioprotective Effects of Finerenone Associated With the Suppression of Myocardial Sodium Accumulation in Aldosterone/Salt‐Loaded Rats},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.044798}
}
Kostenlos starten →